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TNF-a and Th2 Cytokines Induce Atopic Dermatitis–
Like Features on Epidermal Differentiation Proteins
and Stratum Corneum Lipids in Human Skin
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Mogbekeloluwa O. Danso1, Vincent van Drongelen1,2, Aat Mulder2, Jeltje van Esch1, Hannah Scott1,
Jeroen van Smeden1, Abdoelwaheb El Ghalbzouri2 and Joke A. Bouwstra1
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which the skin barrier function is disrupted. In
this inflammatory AD environment, cytokines are upregulated, but the cytokine effect on the AD skin barrier is
not fully understood. We aimed to investigate the influence of Th2 (IL-4, IL-13, IL-31) and pro-inflammatory
(tumor necrosis factor alpha (TNF-a)) cytokines on epidermal morphogenesis, proliferation, differentiation, and
stratum corneum lipid properties. For this purpose, we used the Leiden epidermal model (LEM) in which the
medium was supplemented with these cytokines. Our results show that IL-4, IL-13, IL-31, and TNF-a induce
spongiosis, augment TSLP secretion by keratinocytes, and alter early and terminal differentiation-protein
expression in LEMs. TNF-a alone or in combination with Th2 cytokines decreases the level of long chain free
fatty acids (FFAs) and ester linked o-hydroxy (EO) ceramides, consequently affecting the lipid organization. IL-31
increases long chain FFAs in LEMs but decreases relative abundance of EO ceramides. These findings clearly show
that supplementation with TNF-a and Th2 cytokines influence epidermal morphogenesis and barrier function. As
a result, these LEMs show similar characteristics as found in AD skin and can be used as an excellent tool for
screening formulations and drugs for the treatment of AD.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease
with clinical manifestations of erythema, dryness, and pruritus
(Leung and Bieber 2003; Cork et al., 2006). The epidermal
barrier is disrupted in both lesional and non-lesional AD skin
and characterized by the presence of Th1, Th2 and Th22
immune responses (Neis et al., 2006; Gittler et al., 2012). The
interaction between cytokines and the skin barrier is not yet
fully understood. Therefore, this study aims to determine
whether cytokines influence lipid and protein synthesis in
the epidermis and as a consequence affect skin barrier lipid
composition and organization.
A fully differentiated epidermis consists of a proliferating
stratum basale (SB), differentiating stratum spinosum (SS),
stratum granulosum (SG) and stratum corneum (SC). In the
basal layer, keratinocytes synthesize proteins such as keratin 5
and 14, while differentiating keratinocytes synthesize proteins
such as keratin 10 (K10), filaggrin, involucrin and loricrin. The
latter three proteins are associated with the cornified envel-
ope, a surrounding layer of the corneocytes, located in the SC
(Steven et al., 1990; Ishida-Yamamoto et al., 1993). Filaggrin
especially plays an important role in AD because the
occurrence of AD is strongly associated with mutations in
the filaggrin gene encoding the barrier protein filaggrin
(Palmer et al., 2006; Rodrı´guez et al., 2008; Brown and
McLean 2009; Akiyama 2010). The skin barrier lipids, which
are located within the SC also play a role in AD as changes in
their chain length distribution correlate with an impaired skin
barrier (Janssens et al., 2012). The SC contains a highly
organized lipid matrix located in the intercellular spaces
between the corneocytes. The organization and composition
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of the SC lipid matrix is crucial for a competent skin barrier
(Elias et al., 2003; Feingold 2007). The main lipid classes in
human SC are ceramides (CER), free fatty acids (FFAs) and
cholesterol. Twelve CER subclasses have been identified in
human SC with broad chain length distributions observed with
FFA and CERs (Wertz et al., 1985; Masukawa et al., 2009; van
Smeden et al., 2011). SC lipids form ordered crystalline
lamellar phases with repeat distances of 13 nm (long
periodicity phase, LPP) and 6 nm (short periodicity phase,
SPP) (Bouwstra et al., 1991; Supplementary Figure S1 online).
Within the lamellae, the lipids form mainly, an orthorhombic
(dense) lateral packing in human SC, while a fraction of lipids
are organized in a hexagonal (less dense) lateral packing
(Gay et al., 1994; Pilgram et al., 2001; Supplementary
Figure S1 online). The CER subclass distribution of AD skin
varies from healthy skin (Imokawa et al., 1991; Yamamoto
et al., 1991; Di Nardo et al., 1998; Bleck et al., 1999;
Jungersted et al., 2010). In addition, AD skin shows i) a
decrease in very long chain CERs, ii) reduction in long chain
FFAs level and iii) increased level of unsaturated FFAs
(Ishikawa et al., 2010; Janssens et al., 2012; van Smeden
et al., 2014). These changes are more prominent in lesional
than in non-lesional AD skin and correlates with a less dense
SC lipid lateral packing and reduced skin barrier function (van
Smeden et al., 2014).
It is hypothesized that a disrupted barrier in AD makes
the skin vulnerable to penetration of allergens/irritants through
the skin, causing a Th2 immune response in the epidermis.
Keratinocytes respond to this by secreting thymic stromal
lymphopoietin (TSLP). TSLP activates dendritic cells
(Watanabe et al., 2004) which further enhances the immune
response by proliferation and differentiation of CD4þ T-cells.
TSLP is also considered to be a link between AD and the
development of asthma/atopic march (Zhu et al., 2011).
The aim of this study was to investigate the direct role
cytokines play in the development of pathophysiological
changes occurring in AD skin focusing on both lipids
and epidermal differentiation proteins. Therefore, we
used 3-dimensional (3D) tissue engineered human skin
equivalents, namely the Leiden epidermal model (LEM), since
it harbors a fully differentiated epidermis (El Ghalbzouri et al.,
2008). The culture medium was supplemented with IL-4,
IL-13, IL-31 (Th2 cytokines) and TNF-a (pro-inflammatory
cytokine) singly or a combination during generation of the
LEMs. If the supplemented LEMs mimic several features of AD
skin, the in vitro skin models can be used to examine
pharmacologic interventions for AD. This is due to the need
for in vitro skin models that mimic important features of AD
skin due to large variations in skin architecture between the
commonly used mice skin and human skin and limitations in
the number of drugs that can be tested at a time during a
clinical study.
Our results show that cytokines contribute to the changes in
epidermal morphology, differentiation and skin barrier lipids
observed in AD. This demonstrates that the LEM is an
excellent model for studying the pharmacological intervention
of topical formulations for the treatment of AD in in vitro
settings.
RESULTS
Cytokines influence epidermal organization and differentiation
First, we examined the morphology of LEMs supplemented
with cytokines. In control LEMs, all epidermal strata are
present. LEMs supplemented with IL-4, IL-13 or IL-31 also
show the presence of all epidermal strata. However, spongio-
tic lesions i.e. inter-cellular oedema of keratinocytes, is
present within the lower layers of the epidermis. LEMs
supplemented with TNF-a only, show spongiosis and flatter
suprabasal keratinocytes than the control. In LEMs stimulated
with Th2 cytokines, with or without TNF-a, spongiosis and a
comparable thickness of the viable epidermis was observed as
with single supplementations (Figure 1a).
Next, the influence of these cytokines on epidermal differ-
entiation-protein expression was examined by immunohisto-
chemical (IHC) staining. K10 is expressed in all suprabasal
layers in control LEMs (Figure 1a). However, in LEMs with
single supplementations of Th2 cytokines or TNF-a, the SB
and sections of the lower SS do not express K10. The
combination of Th2 cytokines with or without TNF-a, show
also this delayed K10 expression (Figure 1a). In control and
cytokine stimulated LEMs, filaggrin is expressed in the SG and
the interface between the SG and the SC. However, all
cytokine stimulated LEMs show reduced filaggrin staining than
control LEMs (Figure 1a). qPCR and western blotting analysis
also show that these cytokines significantly reduce mRNA and
protein expression of filaggrin (Supplementary Figure S2
online, Figure 1b respectively). The expression of loricrin was
observed in the SG in both control and cytokine treated LEMs
but cytokine stimulated LEMs show discontinuous or patchy
expression of loricrin compared with control LEMs (Figure 1a).
Th2 cytokines and TNF-a reduced loricrin mRNA expression
(38–68%), however, not significantly (Supplementary Figure S2
online). Loricrin protein expression was only clearly reduced
with IL-13 or a combination of Th2 cytokines. This is different
from the effect of cytokines on filaggrin expression.
Cytokines increase basal cell proliferation and TSLP secretion of
keratinocytes
After analyzing the expression of epidermal differentiation
proteins in cytokine supplemented LEMs, we further examined
basal keratinocyte proliferation by Ki67 staining. Compared
with control LEMs, basal cell proliferation increased signifi-
cantly with the supplementation of IL-4, IL-31 or TNF-a, whilst
IL-13 did not affect basal cell proliferation (Figure 2a). The Th2
cytokine mixture with or without TNF-a significantly increased
basal keratinocyte proliferation compared with control LEMs.
LEMs with increased basal proliferation also show delayed
K10 expression and reduced filaggrin expression except for
supplementation of IL-13.
Supplementation of single cytokines or a combination
enhanced significantly medium TSLP levels (Po0.05;
Figure 2b) compared with the control. There was no significant
difference in TSLP levels between supplementation of single
cytokines and a combination of only Th2 cytokines (P40.05–
0.95). In addition, TSLP secretion was not significantly different
in LEMs when comparing the mixture of only Th2 cytokines,
with the mixture of Th2 cytokines and TNF-a (P¼ 0.27).
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TNF-a and IL-31 affect SC lipid composition in LEMs
After profiling the effect of these cytokines on epidermal
morphology and protein expression, we focused on the SC
lipid barrier properties. The main SC lipid subclasses CER,
cholesterol and FFAs are present in the LEM irrespective of
cytokine addition (Figure 2c). In addition, the total amount of
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Figure 1. TNF-a and Th2 cytokines alter morphology and epidermal protein expression in Leiden epidermal models (LEMs). (a) Cross sections of LEMs cultured in
the presence or absence of cytokines. 20x Magnification; scale bar¼ 50mm. A black dotted line demarcates the viable epidermis from the stratum corneum. Overall
morphology was assessed with hematoxylin and eosin (HE) staining and immunohistochemical analysis was performed for K10, filaggrin, and loricrin. Staining
of the stratum corneum is considered background/non-specific. (b) Filaggrin western blot of cytokine stimulated and control LEMs (HS, human skin; C, control;
All(þ )TNF-a, combination of IL-4, IL-13, IL-31, and TNF-a; All( )TNF-a, combination of IL-4, IL-13, IL-31). Th2, T helper type-2; TNF-a, tumor necrosis factor alpha.
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inter-cellular SC lipids did not change with cytokine sti-
mulation (Supplementary Table S4 online). TNF-a singly or
in combination with Th2 cytokines significantly increased the
percentage of CERs and reduced cholesterol levels in LEMs
(Supplementary Table S4 online). We further analyzed the
lipids with liquid chromatography coupled to mass spectro-
metry (LC-MS), examining CER subclasses and chain length
distribution of saturated FFAs (SFA) and mono-unsaturated
FFAs (MUFA). We focused on the even FFA chain lengths
since the odd chain lengths in total contributedo5% of the
total FFA content.
No significant changes were induced in the total SFA and
MUFA with cytokine treatment (data not shown). However,
when focusing on SFA chain length distribution in LEMs
stimulated with either TNF-a or the combination of Th2
cytokines with TNF-a, we observe an interesting trend where
the relative abundance of SFAX20 carbon atoms (C20:0) is
reduced compared with control LEMs. Although the individual
FFA chain lengths were not significantly decreased, this trend
in the reduction of the relative abundance of SFAXC20:0 is
significant (Po0.01; Figure 3a). The presence of IL-31 in the
culture medium increased the relative abundance of
SFAXC20:0 compared with control LEMs. Although the
changes in individual chain lengths are minor, the trend in
the persistent increase in SFAXC20:0 is significant (Po0.05;
Figure 3c, Supplementary Figure S5 online, absolute values in
Supplementary Table S5 online). There was no significant
difference in the levels of MUFA in LEMs treated with IL-31,
TNF-a or combination of Th2 cytokines and TNF-a, compared
with control LEMs (Figure 3b and d). IL-4, IL-13 and the
combination of Th2 cytokines did not affect the chain length
distribution of SFA and MUFA (Supplementary Figure S4
online, absolute values in Supplementary Table S4 and S6
online). The mRNA and protein expression of the enzyme
elongase 1 (ELOVL1) which is involved in the production of
long chain FFAs was analyzed by qPCR and immunofluores-
cence respectively. The mRNA abundance in LEMs treated
with TNF-a and IL-31 was approximately two times lower
than the control LEMs although this reduction was not stati-
stically significant (Supplementary Figure S6a online). How-
ever, ELOVL1 mRNA levels with the combination of Th2
cytokines and TNF-a was slightly higher compared to control
LEMs (Supplementary Figure S6a online). ELOVL1 protein
expression is present in the entire epidermis with the highest
expression in the SG and upper SS in the control and IL-31
supplemented LEMs. This high expression of ELOVL1 at the
SG and upper SS is absent with TNF-a singly or in combina-
tion with Th2 cytokines compared with the control (Figure 3e).
The LC-MS CER profile shows 12 CER subclasses in control,
IL-31 and TNF-a supplemented LEMs (Figure 4a,b and c). The
four CERs with higher masses in the upper part of the mass
spectrogram belong to the EO subclasses (ester linked
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Figure 2. Basal cell proliferation, TSLP secretion, and SC lipid composition (HPTLC) of cytokine supplemented Leiden epidermal models (LEMs). (a) Proliferation
index (PI) in LEMs supplemented with cytokines singly or in combination. The PI was determined as the percentage of Ki67 positive nuclei compared to
total basal cells. (b) TSLP secretion by LEMs analyzed by ELISA. (c) SC lipid composition analysed by HPTLC of cytokine supplemented LEMs individually or in
combination. The data represent the mean and standard deviation of three independent experiments. Statistical significance is indicated from Student’s t-test
between the control and other culture condition groups (*Pp0.05, **Pp0.01, ***Pp0.001). All(þ )TNF-a, combination of IL-4, IL-13, IL-31, and TNF-a;
All( )TNF-a, combination of IL-4, IL-13, IL-31. HPTLC, high performance thin layer chromatography; SC, stratum corneum; TSLP, thymic stromal lymphopoeitin.
See Supplementary Table S3 online for CER nomenclature according to Motta et al. (1993).
MO Danso et al.
Inducing Atopic Dermatitis Features In Vitro
1944 Journal of Investigative Dermatology (2014), Volume 134
o-hydroxy CER subclasses). The a-hydroxy (A) and non-
hydroxy (N) CER subclasses have shorter chains and lower
masses (non-EO CERs). The total peak area ratios of EO
CERs:non-EO CERs was significantly reduced in TNF-a and
IL-31 supplemented LEMs compared with the control
(Po0.05; Figure 4d, absolute values in Supplementary Table
S7 online) demonstrating a lower relative level of EO CERs.
Ceramide synthase 3 (CerS3) is responsible for linking the very
long acyl chains to the sphingoid base and is particularly
involved in the synthesis of EO CERs. A two fold reduction in
CerS3 mRNA abundance was observed in LEMs supplemented
with IL-31 and TNF-a compared with the control, although the
reduction was not statistically significant (Supplementary
Figure S6b online). However, LEMs with the combination of
Th2 cytokines and TNF-a show similar CerS3 mRNA levels as
in the control LEMs (Supplementary Figure S6b online). CerS3
on protein level is expressed in the entire epidermis with the
highest expression at the SG and upper SB in the control. The
treatment with IL-31 resulted in a reduction in the expression
of CerS3 in suprabasal layers. However, LEMs treated with
TNF-a alone or in combination with Th2 cytokines showed
only CerS3 expression in the granular layer (Figure 4e).
TNF-a changes SC lipid organization in LEMs
The effect of inflammation on the lipid organization remains
unknown, therefore the lamellar organization in SC was
examined using small angle X-ray diffraction (SAXD). Diffrac-
tion profiles of both control and cytokine supplemented LEM
show four diffraction peaks representing the first, second and
third order peak of the LPP and cholesterol respectively
(referred to as 1, 2, 3 and *, Figure 5a and b). Supplementing
LEMs with TNF-a or Th2 cytokines and TNF-a combined,
significantly reduced the LPP repeat distance (P¼0.06 and
P¼0.02 respectively; Figure 5c) compared with the control
LEMs. All other supplementations did not significantly affect
the LPP repeat distance.
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indicated from a two-way ANOVA test between the control and other culture condition groups (*Pp0.05, **Pp0.01). FFAs, free fatty acids; LEM, Leiden
epidermal model; TNF-a, tumor necrosis factor alpha.
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Using FTIR, the lateral organization of the SC lipids was
examined as a function of temperature from the CH2 rocking
vibrations of the FTIR spectrum. In an orthorhombic (dense)
lipid packing, the CH2 rocking region consists of vibrations at
719 and 730 cm 1, whilst a hexagonal (less dense) lateral
organization results in a vibration at 719 cm1. All LEMs
show a strong vibration band at 719 cm 1 and a weak band at
730 cm1 between 0 and 20 1C. This demonstrates that below
20 1C the lipids mainly form a hexagonal lateral packing and
small orthorhombic domains. Above 20 1C, a single peak is
observed at 719 cm1 showing only hexagonal lateral pack-
ing (Supplementary Figure S3a, b online).
The CH2 stretching vibration provides information about the
conformational disordering of the lipids. Crystalline packing
results in low conformational disorder and symmetric
stretching frequencies below 2,850 cm1. High conforma-
tional disorder is observed in a liquid phase with symmetric
stretching frequencies X2,852 cm1. The midpoint tempera-
ture of the transition (MTT) from crystalline to liquid phase
was determined as described by Thakoersing et al., 2012
(Supplementary Figure S3c online). The addition of TNF-a
significantly reduced the MTT (P¼0.03). The CH2 stretching
band position at 32 1C did not statistically differ from the
control after the various supplementations (Supplementary
Figure S3d online).
DISCUSSION
In the present study we showed the effect of Th2 cytokines and
TNF-a on epidermal and SC lipid characteristics. As the
concentrations of IL-4, IL-13, IL-31 and TNF-a in AD skin
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remain unknown, the cytokine concentrations added to the
LEMs was based on a dose dependent study (data not shown).
We selected the cytokine concentrations that induced the
highest TSLP levels whilst maintaining viable keratinocytes.
We show that Th2 cytokines and TNF-a induce both,
epidermal and SC lipid changes characteristic of AD skin.
These conclusions are based on the following findings.
Firstly, TNF-a singly or in combination with Th2 cytokines
induces modulation in barrier lipid properties, observed in AD
lesional skin. The abundance of FFAsXC20:0 was observed to
be reduced in lesional skin compared to healthy skin (van
Smeden et al., 2014). TNF-a singly or in combination with
Th2 cytokines caused a coordinated reduction in the relative
abundance of saturated FFAsXC20:0. This effect on FFA chain
length distribution is larger with a combination of Th2
cytokines and TNF-a than TNF-a alone. ELOVL1 plays a
role in the synthesis of long chain FFAs (Cameron et al., 2007;
Ohno et al., 2010). Our results show that TNF-a alone
or in combination with Th2 cytokines reduce ELOVL1
protein expression and this change may consequently affect
epidermal permeability (Cameron et al., 2007). This reduction
of ELOVL1 expression on protein level was not observed on
mRNA level with TNF-a in combination with Th2 cytokines.
Since mRNA levels only predict 40% of protein abundance
(de Sousa et al., 2009), we suggest that this cytokine
combination may mainly influence translational and/or post-
translational mechanisms of ELOVL1 rather than the
transcription process.
A reduced level of EO CER subclasses and lower average
CER chain length is observed in AD skin which strongly
correlates to SC barrier function (Ishikawa et al., 2010;
Janusova et al., 2011; Janssens et al., 2012). The mRNA
expression of CerS3 was not significantly altered with TNF-a.
However, we observe reduced CerS3 protein expression with
IL-31 and TNF-a followed by a reduction in the ratio of EO
CER:non-EO CER levels. As a result, the effect of IL-31 and
TNF-a on CerS3 expression and CER composition may
therefore be involved in CER changes in AD. Furthermore,
IFN-g has also been suggested to decrease long chain CER NS
via down regulation of ELOVL1 and CerS3 mRNA expression
in a 3 dimensional epidermal model, suggesting its involve-
ment in CER synthesis in AD and psoriasis (Tawada et al.,
2013). As LEMs do not desquamate, the lipid composition of
the LEMs is a combination of the entire culture period. This
includes the first 10 days of culture without supplementation
of cytokines. Therefore, the effects observed in this in vitro
model may be an underestimation of the in vivo situation.
Sawada et al., 2012 reports that TNF-a increases and IL-4
decreases the total CER levels in epidermal equivalents. We
observe an increase in CER levels with TNF-a but no effect
with IL-4. These differences may arise from differences in the
experimental set-up. In the studies of Sawada et al., cytokines
were added to the cultures after they were fully generated,
however, in the present study, the cytokines were added
immediately after a stratified epidermis has been produced.
The lipid synthesis may therefore differ based on the time
point of IL-4 stimulation. Hatano et al., 2005 using human
epidermal sheets showed that TNF-a alone does not affect the
CER/protein ratio after 3 days of treatment, which is a much
shorter period as used in the present study.
Secondly, TNF-a alone or combined with Th2 cytokines
significantly reduces the repeat distance of the LPP and TNF-a
alone reduces the MTT in comparison to control. The changes
in lipid organization can easily be explained by a reduced
chain length of the lipids for the following reasons i) shorter
lipid chains result in lower number of carbon atoms bridging
the lamellae leading to a shorter LPP and ii) a reduction in
saturated long chain FFAs is known to reduce the MTT (Groen
et al., 2011), contributing to a higher trans epidermal water
loss (van Smeden et al., 2014).
Thirdly, we show that TNF-a and Th2 cytokines significantly
augment TSLP secretion compared to the control LEMs, as
observed in AD (Lee et al., 2010). Previous studies show that
the combination of Th2 cytokines and TNF-a induces TSLP
production in full thickness human skin explants, however,
TNF-a alone has no effect on TSLP levels in their model
system (Bogiatzi et al., 2007). The levels of TSLP produced are
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Figure 5. TNF-a reduces the repeat distance of the LPP and the lipid mid-
transition temperature in LEMs. (a) The X-ray curve of control, single cytokine
supplemented LEMs, and (b) LEMs supplemented with a combination of
cytokines. (c) Repeat distance of the LPP for each culture condition. (d) The
mid-transition temperature (MTT) from the CH2 stretching position of the FTIR
spectrum. MTT is calculated as the average of the wavenumber at the
beginning and end of the transition (see Supplementary Figure S3c online). The
MTT is therefore the temperature at this calculated wave number. The data
represent the mean and standard deviation of 2-3 samples (*Pp0.05).
All(þ )TNF-a, combination of IL-4, IL-13, IL-31 and TNF-a; All(–)TNF-a,
combination of IL-4, IL-13, IL-31. FTIR, Fourier transformed infrared
spectroscopy; LEMs, Leiden epidermal models; LPP, long periodicity phase;
TNF-a, tumor necrosis factor alpha.
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also higher than observed in our study with LEMs. We suggest
that i) the presence of dendritic cells in full thickness skin and
ii) a direct effect from the presence of fibroblasts since they
have been shown to express TSLP mRNA in vitro (Soumelis
et al., 2002) may contribute to these differences. Therefore,
LEMs may provide a good model to examine the direct
influence of cytokines on keratinocytes.
Fourthly, stimulation of LEMs with IL-4, IL-13, IL-31 and
TNF-a induce spongiosis in LEMs similarly as observed in AD
(Soter 1989). We also show that IL-31 influences epidermal
cohesion in addition to its known effects in regulating
keratinocyte differentiation and pruritus in AD (Takaoka
et al., 2006; Cornelissen et al., 2012). IL-4 and IL-13 have
also been reported as inducers of spongiosis in epidermal
models (Ohtani et al., 2009).
Lastly, cytokines examined in this study delay early differ-
entiation and increase proliferation in LEMs in a similar pattern
as observed in AD skin. However, no increase in the thickness
of the viable epidermis was observed contrasting the in vivo
situation (Jensen et al., 2004, Sapuntsova et al., 2011). This
may result from a high epidermal turnover rate (7 days) in
LEMs as compared to 30 days in native human epidermis
(Iizuka 1995). In addition, the delayed K10 expression also
confirms the proliferation increase, as the undifferentiated cells
are escaping to the lower stratum spinosum. Th2 cytokines, in
our experimental conditions, less prominently affect the lipids,
but rather reduce the expression of barrier proteins, filaggrin
and loricrin. We suggest that the Th2 cytokines may affect the
permeability barrier by reducing filaggrin and thus reduce
NMF levels resulting in increased SC pH. This higher pH can
lead to alterations of several enzymes, such as serine proteases
and induce alterations in permeability barrier homeostasis, SC
integrity and cohesion (Hachem et al., 2003).
We show a clear relationship between the effect of
cytokines on proliferation and differentiation. However, these
changes in proliferation and differentiation do not reflect in SC
lipid composition. This suggests that cytokine induced
changes in epidermal differentiation and SC lipid synthesis
are influenced by different pathways. We conclude from this
study that supplementation of LEMs with cytokines (individu-
ally or in synergy) induces several important features of AD
skin in vitro on lipid and protein level. Therefore, these
cytokine supplemented LEMs may serve as an excellent
candidate for the testing of prospective drugs and formulations
for the treatment of AD.
MATERIALS AND METHODS
Cell culture
Normal human keratinocytes (NHK) were isolated from human adult
breast skin donors undergoing cosmetic surgery (Ponec et al., 1997;
Supplementary Materials and Methods online). The skin was collected
after written informed consent from the donors, institutional approval,
and handled according to the Declaration of Helsinki Principles.
Generation of the Leiden epidermal models (LEMs)
LEMs were generated similarly as described by El Ghalbzouri
et al., 2008 with some modifications (Supplementary Materials and
Methods online).
Morphology and immunohistochemistry
Harvested LEMs were fixed in 4% paraformaldehyde (Lommerse
Pharma, Oss, The Netherlands), dehydrated and embedded in
paraffin. 5mm sections were cut, deparaffinized and rehydrated
through graded ethanol series and stained with hematoxylin
(2mg/ml) and eosin (4 mg/ml). Immunohistochemical analysis of
filaggrin, K10, ki67, loricrin, ELOVL1 and CerS3 is described in
Supplementary Materials and Methods online. The primary and
secondary antibodies used are listed in Supplementary Table S2
online. The qPCR and western blot analysis is described in the
Supplementary Materials and Methods online.
ELISA
The culture medium at the end of the culture period was collected
and stored at 20 1C till use. TSLP secretion was quantified using a
TSLP quantikine protein ELISA kit (R&D systems, Abingdon, UK)
according to manufacturer’s instructions. Statistical significance was
performed with paired Student’s t-test comparison between the
control and other culture condition groups.
SC isolation and lipid extraction
The SC from LEM was isolated by trypsin digestion. Lipids were
extracted and pooled from three LEM SC using the modified Bligh and
Dyer (1959) procedure (Thakoersing et al., 2012) with
the addition of 0.25M KCl to extract polar lipids. All extracts were
dried under a stream of nitrogen, reconstituted in chloroform:
methanol (2:1) and stored at  20 1C. For LC-MS analysis the lipids
were dried under a stream of nitrogen and dissolved in
chloroform:methanol:heptane (2.5:2.5:95) at 1mg/ml concentration.
The SC from LEMs were weighed before and after extraction in order
to determine the total intercellular lipid and protein content.
High performance thin layer chromatography (HPTLC)
Extracted lipids were analyzed by HPTLC as described previously
(Ponec et al., 2003). The solvent system used for separation is listed in
Supplementary Table S2 online. Co-chromatography of a standard
lipid mixture was performed to identify the various classes of lipids
consisting of cholesterol, palmitic acid, stearic acid, tricosanoic acid,
behenic acid, arachidic acid, cerotic acid, lignoceric acid (Sigma)
and CER EOH, NS, NP, EOS and AP (Evonik, Germany, according to
the terminology of the ceramide nomenclature of Motta et al., 1993
and Masukawa et al., 2008 used throughout this article,
Supplementary Table S3 online). The liquid chromatography mass
spectrometry analysis is described in the Supplementary Materials
and Methods online.
Fourier transformed infrared spectroscopy and small angle X-ray
diffraction
For FTIR and SAXD, SC samples were hydrated for 24 hours at room
temperature over a 27% (w/v) NaBr solution.
FTIR: the hydrated SC was measured as described previously
(Caussin et al., 2008; Supplementary Materials and Methods online).
The phase transitions of the SC lateral lipid organization was analyzed
with a temperature range of 0 and 90 1C at a rate of 0.25 1C/min.
SAXD: measurements were performed at the European Synchrotron
Radiation Facility (ESRF, Grenoble) at station BM26B. The SC samples
were measured as described before (Thakoersing et al., 2012;
Supplementary Materials and Methods online).
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